OSI leverages foundational deal with Oxford to build its life sciences portfolio
OSI parlays University of Oxford deal into $800M evergreen fund, expanding portfolio
OSI has parlayed its long-term deal with University of Oxford into an $800 million evergreen fund and an expanding life sciences portfolio.
A long-term agreement with the University of Oxford has provided a strong foundation on which investment firm Oxford Sciences Innovation has been able to build its fund-raising and broaden its portfolio into new disease areas and modalities.
Despite Oxford’s more than 800-year history, its arrangement with Oxford Sciences Innovation (OSI) may be its first successful attempt at systematically driving the translation and commercialization of its IP through company creation.
OSI was founded in 2015 as an independent evergreen investment firm on the